Minor changes in electrostatics robustly increase VP40 membrane binding, assembly, and budding of Ebola virus matrix protein derived virus-like particles.

Balindile B Motsa, Tej Sharma, Prem P Chapagain, Robert V Stahelin
Author Information
  1. Balindile B Motsa: Borch Department of Medicinal Chemistry and Molecular Pharmacology and the Purdue Institute of Inflammation, Immunology, and Infectious Disease, Purdue University, West Lafayette, IN 47907, USA.
  2. Tej Sharma: Department of Physics, Florida International University, Miami, FL 33199, USA.
  3. Prem P Chapagain: Department of Physics, Florida International University, Miami, FL 33199, USA. ORCID
  4. Robert V Stahelin: Borch Department of Medicinal Chemistry and Molecular Pharmacology and the Purdue Institute of Inflammation, Immunology, and Infectious Disease, Purdue University, West Lafayette, IN 47907, USA. ORCID

Abstract

Ebola virus (EBOV) is a filamentous negative-sense RNA virus which causes severe hemorrhagic fever. There are limited vaccines or therapeutics for prevention and treatment of EBOV, so it is important to get a detailed understanding of the virus lifecycle to illuminate new drug targets. EBOV encodes for the matrix protein, VP40, which regulates assembly and budding of new virions from the inner leaflet of the host cell plasma membrane (PM). In this work we determine the effects of VP40 mutations altering electrostatics on PM interactions and subsequent budding. VP40 mutations that modify surface electrostatics affect viral assembly and budding by altering VP40 membrane binding capabilities. Mutations that increase VP40 net positive charge by one (e.g., Gly to Arg or Asp to Ala) increase VP40 affinity for phosphatidylserine (PS) and PI(4,5)P in the host cell PM. This increased affinity enhances PM association and budding efficiency leading to more effective formation of virus-like particles (VLPs). In contrast, mutations that decrease net positive charge by one (e.g., Gly to Asp) lead to a decrease in assembly and budding because of decreased interactions with the anionic PM. Taken together our results highlight the sensitivity of slight electrostatic changes on the VP40 surface for assembly and budding. Understanding the effects of single amino acid substitutions on viral budding and assembly will be useful for explaining changes in the infectivity and virulence of different EBOV strains, VP40 variants that occur in nature, and for long-term drug discovery endeavors aimed at EBOV assembly and budding.

Keywords

References

  1. PLOS Glob Public Health. 2023 Jan 25;3(1):e0001083 [PMID: 36962988]
  2. J Virol. 2015 Sep;89(18):9440-53 [PMID: 26136573]
  3. Virol J. 2006 May 23;3:31 [PMID: 16719918]
  4. J Phys Chem B. 2023 Jul 27;127(29):6449-6461 [PMID: 37458567]
  5. Biophys J. 2012 Jun 6;102(11):2517-25 [PMID: 22713567]
  6. J Virol. 2001 Jun;75(11):5205-14 [PMID: 11333902]
  7. PLoS Pathog. 2018 Jan 16;14(1):e1006848 [PMID: 29338048]
  8. J Biol Chem. 2013 Feb 22;288(8):5779-89 [PMID: 23297401]
  9. J Mol Graph. 1996 Feb;14(1):33-8, 27-8 [PMID: 8744570]
  10. J Biol Chem. 2018 Mar 2;293(9):3335-3349 [PMID: 29348171]
  11. J Biol Chem. 2014 Nov 28;289(48):33590-7 [PMID: 25315776]
  12. J Lipid Res. 2024 Jan 29;:100512 [PMID: 38295986]
  13. Pathogens. 2021 Oct 15;10(10): [PMID: 34684279]
  14. Front Microbiol. 2014 Jun 18;5:300 [PMID: 24995005]
  15. Nat Rev Mol Cell Biol. 2008 Feb;9(2):112-24 [PMID: 18216768]
  16. J Virol. 2015 Jun;89(12):6481-93 [PMID: 25855742]
  17. J Mol Biol. 2000 Jun 30;300(1):103-12 [PMID: 10864502]
  18. Cell Host Microbe. 2008 Mar 13;3(3):168-77 [PMID: 18329616]
  19. EMBO Rep. 2022 Nov 7;23(11):e51709 [PMID: 36094794]
  20. Biophys J. 2013 May 7;104(9):1940-9 [PMID: 23663837]
  21. J Chem Phys. 2020 Jul 28;153(4):044130 [PMID: 32752662]
  22. Methods Mol Biol. 2016;1376:141-53 [PMID: 26552681]
  23. Biochem J. 1993 Aug 15;294 ( Pt 1):1-14 [PMID: 8363559]
  24. J Comput Chem. 2004 Oct;25(13):1584-604 [PMID: 15264253]
  25. Antiviral Res. 2009 Mar;81(3):189-97 [PMID: 19114059]
  26. Viruses. 2014 Oct 17;6(10):3837-54 [PMID: 25330123]
  27. J Comput Chem. 2009 Jul 30;30(10):1545-614 [PMID: 19444816]
  28. J Comput Chem. 2008 Aug;29(11):1859-65 [PMID: 18351591]
  29. J Virol. 2002 May;76(10):4855-65 [PMID: 11967302]
  30. Expert Opin Ther Targets. 2014 Feb;18(2):115-20 [PMID: 24283270]
  31. Cell. 2013 Aug 15;154(4):763-74 [PMID: 23953110]
  32. Curr Opin Virol. 2023 Aug;61:101339 [PMID: 37392670]
  33. J Lipid Res. 2020 Jul;61(7):971 [PMID: 32295828]
  34. Sci Rep. 2016 Jan 12;6:19125 [PMID: 26753796]
  35. EMBO J. 2000 Aug 15;19(16):4228-36 [PMID: 10944105]
  36. Vaccines (Basel). 2021 Feb 25;9(3): [PMID: 33668698]
  37. PLoS Pathog. 2006 Sep;2(9):e99 [PMID: 17009868]
  38. Infect Dis Ther. 2024 Jan;13(1):21-55 [PMID: 38240994]
  39. Biochim Biophys Acta Biomembr. 2017 Oct;1859(10):2012-2020 [PMID: 28711356]
  40. Stat Med. 1995 Oct 30;14(20):2227-37 [PMID: 8552899]
  41. PLoS Pathog. 2010 Sep 16;6(9):e1001110 [PMID: 20862315]
  42. Elife. 2020 Oct 05;9: [PMID: 33016878]
  43. Viruses. 2021 Jul 15;13(7): [PMID: 34372582]
  44. Curr Protoc Bioinformatics. 2006 Oct;Chapter 5:Unit-5.6 [PMID: 18428767]
  45. J Comput Chem. 2014 Oct 15;35(27):1997-2004 [PMID: 25130509]
  46. Virol J. 2009 Jun 08;6:75 [PMID: 19505320]
  47. J Virol. 2005 Feb;79(3):1898-905 [PMID: 15650213]
  48. EMBO J. 2000 Dec 15;19(24):6732-41 [PMID: 11118208]
  49. Proteins. 2022 Feb;90(2):340-350 [PMID: 34431571]

Grants

  1. R01 AI158220/NIAID NIH HHS

Word Cloud

Created with Highcharts 10.0.0VP40buddingassemblyvirusEBOVPMmembraneelectrostaticsEbolamutationsinteractionsincreasechangesnewdrugmatrixproteinhostcellplasmaeffectsalteringsurfaceviralbindingnetpositivechargeoneegGlyAspaffinityphosphatidylserinevirus-likeparticlesdecreasefilamentousnegative-senseRNAcausesseverehemorrhagicfeverlimitedvaccinestherapeuticspreventiontreatmentimportantgetdetailedunderstandinglifecycleilluminatetargetsencodesregulatesvirionsinnerleafletworkdeterminesubsequentmodifyaffectcapabilitiesMutationsArgAlaPSPI45PincreasedenhancesassociationefficiencyleadingeffectiveformationVLPscontrastleaddecreasedanionicTakentogetherresultshighlightsensitivityslightelectrostaticUnderstandingsingleaminoacidsubstitutionswillusefulexplaininginfectivityvirulencedifferentstrainsvariantsoccurnaturelong-termdiscoveryendeavorsaimedMinorrobustlyderived5-bisphosphatelipid-proteinphosphatidylinositol-4

Similar Articles

Cited By